These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 26658454)

  • 1. The experimental power of FR900359 to study Gq-regulated biological processes.
    Schrage R; Schmitz AL; Gaffal E; Annala S; Kehraus S; Wenzel D; Büllesbach KM; Bald T; Inoue A; Shinjo Y; Galandrin S; Shridhar N; Hesse M; Grundmann M; Merten N; Charpentier TH; Martz M; Butcher AJ; Slodczyk T; Armando S; Effern M; Namkung Y; Jenkins L; Horn V; Stößel A; Dargatz H; Tietze D; Imhof D; Galés C; Drewke C; Müller CE; Hölzel M; Milligan G; Tobin AB; Gomeza J; Dohlman HG; Sondek J; Harden TK; Bouvier M; Laporte SA; Aoki J; Fleischmann BK; Mohr K; König GM; Tüting T; Kostenis E
    Nat Commun; 2015 Dec; 6():10156. PubMed ID: 26658454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting primary and metastatic uveal melanoma with a G protein inhibitor.
    Onken MD; Makepeace CM; Kaltenbronn KM; Choi J; Hernandez-Aya L; Weilbaecher KN; Piggott KD; Rao PK; Yuede CM; Dixon AJ; Osei-Owusu P; Cooper JA; Blumer KJ
    J Biol Chem; 2021; 296():100403. PubMed ID: 33577798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-hypertensive mechanisms of cyclic depsipeptide inhibitor ligands for G
    Meleka MM; Edwards AJ; Xia J; Dahlen SA; Mohanty I; Medcalf M; Aggarwal S; Moeller KD; Mortensen OV; Osei-Owusu P
    Pharmacol Res; 2019 Mar; 141():264-275. PubMed ID: 30634050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applying Molecular Networking for the Detection of Natural Sources and Analogues of the Selective Gq Protein Inhibitor FR900359.
    Reher R; Kuschak M; Heycke N; Annala S; Kehraus S; Dai HF; Müller CE; Kostenis E; König GM; Crüsemann M
    J Nat Prod; 2018 Jul; 81(7):1628-1635. PubMed ID: 29943987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering Specificity Determinants for FR900359-Derived G
    Reher R; Kühl T; Annala S; Benkel T; Kaufmann D; Nubbemeyer B; Odhiambo JP; Heimer P; Bäuml CA; Kehraus S; Crüsemann M; Kostenis E; Tietze D; König GM; Imhof D
    ChemMedChem; 2018 Aug; 13(16):1634-1643. PubMed ID: 29873888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An experimental strategy to probe Gq contribution to signal transduction in living cells.
    Patt J; Alenfelder J; Pfeil EM; Voss JH; Merten N; Eryilmaz F; Heycke N; Rick U; Inoue A; Kehraus S; Deupi X; Müller CE; König GM; Crüsemann M; Kostenis E
    J Biol Chem; 2021; 296():100472. PubMed ID: 33639168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterologous Expression, Biosynthetic Studies, and Ecological Function of the Selective Gq-Signaling Inhibitor FR900359.
    Crüsemann M; Reher R; Schamari I; Brachmann AO; Ohbayashi T; Kuschak M; Malfacini D; Seidinger A; Pinto-Carbó M; Richarz R; Reuter T; Kehraus S; Hallab A; Attwood M; Schiöth HB; Mergaert P; Kikuchi Y; Schäberle TF; Kostenis E; Wenzel D; Müller CE; Piel J; Carlier A; Eberl L; König GM
    Angew Chem Int Ed Engl; 2018 Jan; 57(3):836-840. PubMed ID: 29194875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thioesterase-mediated side chain transesterification generates potent Gq signaling inhibitor FR900359.
    Hermes C; Richarz R; Wirtz DA; Patt J; Hanke W; Kehraus S; Voß JH; Küppers J; Ohbayashi T; Namasivayam V; Alenfelder J; Inoue A; Mergaert P; Gütschow M; Müller CE; Kostenis E; König GM; Crüsemann M
    Nat Commun; 2021 Jan; 12(1):144. PubMed ID: 33420046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delineation of molecular determinants for FR900359 inhibition of G
    Boesgaard MW; Harpsøe K; Malmberg M; Underwood CR; Inoue A; Mathiesen JM; König GM; Kostenis E; Gloriam DE; Bräuner-Osborne H
    J Biol Chem; 2020 Oct; 295(40):13850-13861. PubMed ID: 32753482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feature-Based Molecular Networking for the Targeted Identification of G
    Hanke W; Patt J; Alenfelder J; Voss JH; Zdouc MM; Kehraus S; Kim JB; Grujičić GV; Namasivayam V; Reher R; Müller CE; Kostenis E; Crüsemann M; König GM
    J Nat Prod; 2021 Jul; 84(7):1941-1953. PubMed ID: 34197116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design of a heterotrimeric G protein α subunit with artificial inhibitor sensitivity.
    Malfacini D; Patt J; Annala S; Harpsøe K; Eryilmaz F; Reher R; Crüsemann M; Hanke W; Zhang H; Tietze D; Gloriam DE; Bräuner-Osborne H; Strømgaard K; König GM; Inoue A; Gomeza J; Kostenis E
    J Biol Chem; 2019 Apr; 294(15):5747-5758. PubMed ID: 30745359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chromodepsins - chemistry, biology and biosynthesis of a selective Gq inhibitor natural product family.
    Hermes C; König GM; Crüsemann M
    Nat Prod Rep; 2021 Dec; 38(12):2276-2292. PubMed ID: 33998635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterotrimeric G
    Kostenis E; Pfeil EM; Annala S
    J Biol Chem; 2020 Apr; 295(16):5206-5215. PubMed ID: 32122969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct targeting of Gα
    Annala S; Feng X; Shridhar N; Eryilmaz F; Patt J; Yang J; Pfeil EM; Cervantes-Villagrana RD; Inoue A; Häberlein F; Slodczyk T; Reher R; Kehraus S; Monteleone S; Schrage R; Heycke N; Rick U; Engel S; Pfeifer A; Kolb P; König G; Bünemann M; Tüting T; Vázquez-Prado J; Gutkind JS; Gaffal E; Kostenis E
    Sci Signal; 2019 Mar; 12(573):. PubMed ID: 30890659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Oncogenic Gα
    Lapadula D; Farias E; Randolph CE; Purwin TJ; McGrath D; Charpentier TH; Zhang L; Wu S; Terai M; Sato T; Tall GG; Zhou N; Wedegaertner PB; Aplin AE; Aguirre-Ghiso J; Benovic JL
    Mol Cancer Res; 2019 Apr; 17(4):963-973. PubMed ID: 30567972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted inhibition of G
    Matthey M; Roberts R; Seidinger A; Simon A; Schröder R; Kuschak M; Annala S; König GM; Müller CE; Hall IP; Kostenis E; Fleischmann BK; Wenzel D
    Sci Transl Med; 2017 Sep; 9(407):. PubMed ID: 28904224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter-Driven Overexpression in Chromobacterium vaccinii Facilitates Access to FR900359 and Yields Novel Low Abundance Analogs.
    Pistorius D; Buntin K; Weber E; Richard E; Bouquet C; Wollbrett S; Regenass H; Peón V; Böhm M; Kessler R; Gempeler T; Haberkorn A; Wimmer L; Lanshoeft C; Davis J; Hainzl D; D'Alessio JA; Manchado E; Petersen F
    Chemistry; 2022 Feb; 28(8):e202103888. PubMed ID: 34878202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic Gq/11 signaling acutely drives and chronically sustains metabolic reprogramming in uveal melanoma.
    Onken MD; Noda SE; Kaltenbronn KM; Frankfater C; Makepeace CM; Fettig N; Piggott KD; Custer PL; Ippolito JE; Blumer KJ
    J Biol Chem; 2022 Jan; 298(1):101495. PubMed ID: 34919964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship and conformational studies of the natural product cyclic depsipeptides YM-254890 and FR900359.
    Zhang H; Nielsen AL; Boesgaard MW; Harpsøe K; Daly NL; Xiong XF; Underwood CR; Haugaard-Kedström LM; Bräuner-Osborne H; Gloriam DE; Strømgaard K
    Eur J Med Chem; 2018 Aug; 156():847-860. PubMed ID: 30055466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total synthesis and structure-activity relationship studies of a series of selective G protein inhibitors.
    Xiong XF; Zhang H; Underwood CR; Harpsøe K; Gardella TJ; Wöldike MF; Mannstadt M; Gloriam DE; Bräuner-Osborne H; Strømgaard K
    Nat Chem; 2016 Nov; 8(11):1035-1041. PubMed ID: 27768111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.